ENTERA BIO LTD
ENTX·M40527109·US·Common Stock·Healthcare - Biotechnology-13D/G
ENTX (ENTERA BIO LTD) is held by 17 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($525,521), CITADEL ADVISORS LLC ($272,590), MARSHALL WACE, LLP ($217,316). Net institutional sentiment: Mixed.
17
Holders
Avg rating(3 Elite)
$1.5M
Total Value
44% (19)
Fund Consensus
7 buying - 9 selling
Who's Trading
InsiderBGBurshtein GregoryVest 88K shMay 7, 2026
InsiderYDYaacov-Garbeli DanaVest 58K shMay 7, 2026
InsiderGHGalitzer HillelVest 73K shMay 7, 2026
InsiderGJGermano Geno JBuy $26KMar 9, 2026
InsiderESEllis SeanBuy $12KMar 5, 2026
InsiderTJToledano Miranda JayneBuy $20KDec 29, 2025
ActivistOHOPKO HEALTH, INC.8.1%Apr 2, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer